MDGL Operating Income Growth
Madrigal Pharmaceuticals Inc · Operating Income Growth
MDGL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-19.29%period ending
MDGL Quarterly Operating Income YoY % (-106.24% → -19.29%)
Year-over-year change
High-resolution chart · PNG
MDGL operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -19.2916% | |
| -16.9106% | |
| 11.026% | |
| 2.0025% | |
| 70.9592% | |
| 47.8344% | |
| 42.8245% | |
| -18.0344% | |
| -88.0127% | |
| -94.0832% | |
| -37.3709% | |
| -22.5364% | |
| -23.0202% | |
| -36.0307% | |
| -32.0398% | |
| -27.3148% | |
| -13.8172% | |
| -8.6978% | |
| -8.4728% | |
| -7.4405% | |
| -22.6817% | |
| -39.4001% | |
| -98.8215% | |
| -142.9676% | |
| -121.6658% | |
| -109.7522% | |
| -107.2368% | |
| -113.4916% | |
| -190.1099% | |
| -156.3163% | |
| -62.204% | |
| -31.2145% | |
| 7.2639% | |
| -16.3621% | |
| -15.9864% | |
| 38.1282% | |
| -141.8745% | |
| 5.7701% | |
| 25.9846% | |
| 19.7452% | |
| 82.1114% | |
| 68.2914% | |
| 47.8235% | |
| 10.5661% | |
| 10.124% | |
| 11.2411% | |
| 15.1425% | |
| 10.7598% | |
| 1.6408% | |
| -13.0763% | |
| -32.4295% | |
| -49.9003% | |
| -56.0988% | |
| -39.0869% | |
| -72.8977% | |
| -18.9966% | |
| -17.6951% | |
| -32.8196% | |
| -22.4029% | |
| -19.4214% | |
| -32.7842% | |
| -18.4489% | |
| -19.8424% | |
| -108.6577% | |
| -6.9916% | |
| 60.495% | |
| 73.0137% | |
| 546.7582% | |
| 63.1629% | |
| -27.0534% | |
| -58.2635% | |
| -71.8267% | |
| -31.381% | |
| -8.4235% | |
| -25.6671% | |
| -5.6047% | |
| -17.0016% | |
| -13.9603% | |
| 16.0534% | |
| 45.3759% | |
| 44.0606% | |
| 19.2994% | |
| -106.2437% |